Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis

Abstract

Background Colon cancer is a worldwide leading cause of cancer-related mortality, and the prognosis of colon cancer is still needed to be improved. This study aimed to construct a prognostic model for predicting the prognosis of colon cancer. Methods The gene expression profile data of colon cancer were obtained from the TCGA, GSE44861, and GSE44076 datasets. The WGCNA module genes and common differentially expressed genes (DEGs) were used to screen out the prognosis-associated DEGs, which were used to construct a prognostic model. The performance of the prognostic model was assessed and validated in the TCGA training and microarray validation sets (GSE38832 and GSE17538). At last, the model and prognosis-associated clinical factors were used for the construction of the nomogram. Results Five colon cancer-related WGCNA modules (including 1160 genes) and 1153 DEGs between tumor and normal tissues were identified, inclusive of 556 overlapping DEGs. Stepwise Cox regression analyses identified there were 14 prognosis-associated DEGs, of which 12 DEGs were included in the optimized prognostic gene signature. This prognostic model presented a high forecast ability for the prognosis of colon cancer both in the TCGA training dataset and the validation datasets (GSE38832 and GSE17538; AUC > 0.8). In addition, patients’ age, T classification, recurrence status, and prognostic risk score were associated with the prognosis of TCGA patients with colon cancer. The nomogram was constructed using the above factors, and the predictive 3- and 5-year survival probabilities had high compliance with the actual survival proportions. Conclusions The 12-gene signature prognostic model had a high predictive ability for the prognosis of colon cancer.

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients

“…WDR78 is essential for ciliary beating and axonemal dyneins. Studies showed that WDR78 has been enrolled in the molecular signatures for predicting the prognosis of CRCpts ( 63 , 64 ). In further studies, we will explore the specific roles and mechanisms of the five genes in 5-Fu resistance in CRC.…”

LINC01224 promotes colorectal cancer progression through targeting miR-485-5p/MYO6 axis

“…Additionally, there is a reported prognostic signature of 6-lncRNA and 12-gene for CRC [ 37 , 38 ]. Like the data of the TCGA database, we also found LINC01224 abundance was elevated in CRC.…”

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma

“…Least Absolute Shrinkage and Selection Operator (LASSO) is a commonly used regularization in many regression analysis methods for variable selection and shrinkage in Cox's proportional hazards model [28]. Lasso penalized Cox regression analysis have been widely used to construct gene expression based signatures in various cancers [29][30][31]. In our study, the FRlncRNAs were used as input of Lasso Cox regression to construct a FRlncRNA signature.…”